|
Real-time
Boerse Muenchen
08:31:24 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 26.10 EUR | 0.00% |
|
-1.51% | -12.42% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-06 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 446M 520M 418M 383M 721M 49.65B 723M 4.95B 1.93B 25.02B 1.95B 1.91B 82.81B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 398M 464M 373M 342M 643M 44.32B 645M 4.42B 1.73B 22.34B 1.74B 1.7B 73.93B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 week | -1.14% | ||
| Current month | -3.69% | ||
| 1 month | -3.69% | ||
| 3 months | -5.43% | ||
| 6 months | -3.33% | ||
| Current year | -12.42% |
| 1 week | 26.1 | 26.4 | |
| 1 month | 26.1 | 27.5 | |
| 3 years | 20.5 | 55.9 | |
| 5 years | 20.5 | 55.9 | |
| 10 years | 20.5 | 91.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -1.51% | +23.99% | -50.75% | 520M | ||
| +1.01% | +1.01% | -13.78% | -5.57% | 13.27B | ||
| +1.98% | +0.33% | -35.14% | -57.05% | 4.97B | ||
| +1.85% | -5.05% | -6.75% | -2.34% | 4.65B | ||
| +1.58% | -4.23% | -1.29% | -28.74% | 4.04B | ||
| +1.01% | +0.61% | -21.17% | +5.44% | 3.59B | ||
| +2.21% | +3.87% | -6.13% | -3.71% | 3.46B | ||
| -0.47% | -4.16% | -13.69% | +11.83% | 3.29B | ||
| +0.86% | -3.04% | -19.63% | -15.55% | 2.43B | ||
| +1.82% | -1.23% | -31.46% | -11.34% | 1.71B | ||
| Average | +1.32% | -1.10% | -12.51% | -15.78% | 4.6B | |
| Weighted average by Cap. | +1.28% | -0.82% | -14.92% | -12.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 568M 456M 418M 787M 54.25B 790M 5.41B 2.11B 27.34B 2.13B 2.09B 90.48B | 501M 584M 469M 430M 809M 55.75B 812M 5.56B 2.17B 28.1B 2.19B 2.14B 93B |
| Net income | 11.34M 13.21M 10.61M 9.72M 18.31M 1.26B 18.36M 126M 49.13M 636M 49.58M 48.51M 2.1B | 32.64M 38.03M 30.56M 27.98M 52.72M 3.63B 52.87M 362M 141M 1.83B 143M 140M 6.06B |
| Net Debt | -49.74M -57.94M -46.57M -42.64M -80.32M -5.53B -80.55M -551M -216M -2.79B -218M -213M -9.23B | -47.86M -55.75M -44.8M -41.03M -77.28M -5.32B -77.5M -531M -207M -2.68B -209M -205M -8.88B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change |
|---|---|---|
| 28/08/26 | €26.10 | 0.00% |
| 27/08/26 | €26.10 | 0.00% |
| 26/08/26 | €26.10 | -0.38% |
| 25/08/26 | €26.20 | -0.76% |
| 24/08/26 | €26.40 | 0.00% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BON Stock
Select your edition
All financial news and data tailored to specific country editions
















